Chengdu Anjian Likang Biotechnology Co.
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 2
About Chengdu Anjian Likang Biotechnology Co.
, Ltd. provides drug discovery solutions for the healthcare industry. The company was established to focus on the research and innovation of ENDOD1 small molecule inhibitors. The company works with medical researchers to provide small molecule inhibitors" and develops "ENDOi," a targeted drug that has shown progression-free, partial, or complete response results in treating high grade serous ovarian cancer and advanced pancreatic cancer. The company’s revenue is generated by the research and development of biopharmaceutical products. The company plans to accelerate the research and development of its ENDOD1 small molecule inhibitors, specifically aiming to submit IND applications in China and the United States in 2026 and to expand its market layout.
Who invested in Chengdu Anjian Likang Biotechnology Co.
2 investors across 1 round
See all investors in Chengdu Anjian Likang Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 26, 2026
Amount
Undisclosed
Investors
Questions about Chengdu Anjian Likang Biotechnology Co.
Who invested in Chengdu Anjian Likang Biotechnology Co.?
Chengdu Anjian Likang Biotechnology Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Chengdu Anjian Likang Biotechnology Co. raised?
Chengdu Anjian Likang Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Chengdu Anjian Likang Biotechnology Co. last raise money?
Chengdu Anjian Likang Biotechnology Co.'s most recent round on record is a Series A, in Jan 2026.
What does Chengdu Anjian Likang Biotechnology Co. do?
Chengdu Anjian Likang Biotechnology Co. is a biotechnology company.
Where is Chengdu Anjian Likang Biotechnology Co. headquartered?
Chengdu Anjian Likang Biotechnology Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Chengdu Anjian Likang Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Chengdu Anjian Likang Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Chengdu Anjian Likang Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.